These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 8085851

  • 1. [Innate resistance to thymidylate synthase inhibition after 5-fluorouracil treatment--a rationale of combined use of cisplatin and its optimal administration dose].
    Omura K, Hashimoto T, Kawakami K, Kanehira E, Watanabe T, Hirano K, Watanabe S, Watanabe Y, Shirasaka T.
    Gan To Kagaku Ryoho; 1994 Sep; 21(12):2007-11. PubMed ID: 8085851
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Comparison between leucovorin and cisplatin as a modulator of 5-fluorouracil].
    Iba T, Yagi Y, Kidokoro A, Fukunaga T.
    Gan To Kagaku Ryoho; 1993 Mar; 20(4):479-83. PubMed ID: 8452385
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Antitumor activity and function of S-1, a new oral tegafur-based formulation].
    Fukushima M.
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():19-26. PubMed ID: 16897968
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A potential important role for thymidylate synthetase inhibition on antitumor activity of fluoropyrimidine and raltitexed.
    Kabeshima Y, Kubota T, Watanabe M, Saikawa Y, Nishibori H, Hasegawa H, Kitajima M.
    Anticancer Res; 2002 Jun; 22(6A):3245-52. PubMed ID: 12530071
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Schedule-dependent synergism of vinorelbine and 5-fluorouracil/UFT against non-small cell lung cancer.
    Matsumoto S, Igishi T, Hashimoto K, Kodani M, Shigeoka Y, Nakanishi H, Touge H, Kurai J, Makino H, Takeda K, Yasuda K, Hitsuda Y, Shimizu E.
    Int J Oncol; 2004 Nov; 25(5):1311-8. PubMed ID: 15492820
    [Abstract] [Full Text] [Related]

  • 16. Preliminary study of the optimal dosing schedule for oral UFT/leucovorin chemotherapy.
    Sadahiro S, Suzuki T, Ishikawa K, Nakamura T, Saguchi T, Kamijo A, Yasuda S, Makuuchi H, Murayama C.
    Anticancer Res; 2004 Nov; 24(2B):625-30. PubMed ID: 15161004
    [Abstract] [Full Text] [Related]

  • 17. [Study of preoperative combination therapy with UFT + CDDP in patients with gastric and colorectal cancer--concomitant effects based on the thymidylate synthase inhibitory rat].
    Mitsuishi K, Umeno T, Tanaka S, Kimura H, Fuchino Y, Tomita A, Ikeda S.
    Gan To Kagaku Ryoho; 1997 Jul; 24(9):1119-24. PubMed ID: 9239165
    [Abstract] [Full Text] [Related]

  • 18. Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1-(2'-tetrahydrofuryl)-5-fluorouracil.
    Ho DH, Pazdur R, Covington W, Brown N, Huo YY, Lassere Y, Kuritani J.
    Clin Cancer Res; 1998 Sep; 4(9):2085-8. PubMed ID: 9748123
    [Abstract] [Full Text] [Related]

  • 19. Methylenetetrahydrofolate reductase polymorphism is associated with folate pool in gastrointestinal cancer tissue.
    Kawakami K, Omura K, Kanehira E, Watanabe G.
    Anticancer Res; 2001 Sep; 21(1A):285-9. PubMed ID: 11299748
    [Abstract] [Full Text] [Related]

  • 20. Effects of UFT on thymidylate synthase and dihydropyrimidine dehydrogenase activities in lung cancer.
    Miyamoto H, Morio A, Izumi H, Yamazaki A, Wang Z, Futagawa T, Sonobe S.
    Anticancer Res; 2003 Sep; 23(5b):4153-6. PubMed ID: 14666617
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.